Found: 7
Select item for more details and to access through your institution.
Follow‐up of SARS‐CoV‐2 positive subgroup from the Asymptomatic novel CORonavirus iNFection study.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 5, p. 2925, doi. 10.1002/jmv.26810
- By:
- Publication type:
- Article
A cross‐sectional community‐based observational study of asymptomatic SARS‐CoV‐2 prevalence in the greater Indianapolis area.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 11, p. 2874, doi. 10.1002/jmv.26182
- By:
- Publication type:
- Article
CURB-65, PSI, and APACHE II to Assess Mortality Risk in Patients With Severe Sepsis and Community Acquired Pneumonia in PROWESS.
- Published in:
- Journal of Intensive Care Medicine, 2011, v. 26, n. 1, p. 34, doi. 10.1177/0885066610383949
- By:
- Publication type:
- Article
Efficacy and safety of an expanded dulaglutide dose range: A phase 2, placebo‐controlled trial in patients with type 2 diabetes using metformin.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 9, p. 2048, doi. 10.1111/dom.13764
- By:
- Publication type:
- Article
Body weight and eGFR during dulaglutide treatment in type 2 diabetes and moderate‐to‐severe chronic kidney disease (AWARD‐7).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 6, p. 1493, doi. 10.1111/dom.13668
- By:
- Publication type:
- Article
Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 2, p. 637, doi. 10.1007/s13300-018-0377-5
- By:
- Publication type:
- Article
233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-233-OR
- By:
- Publication type:
- Article